An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC).

被引：0
|
作者：
Van Damme, N.
De Bruyne, S.
Mertens, J.
Van de Wiele, C.
Ceelen, W. P.
Smeets, P.
Ferdinande, L.
Laurent, S.
Geboes, K.
Peeters, M.
机构：
[1] Ghent Univ Hosp, Dept Surg, Ghent, Belgium
[2] Ghent Univ Hosp, Dept Pneumol, Ghent, Belgium
[3] Ghent Univ Hosp, Dept Nucl Med, Ghent, Belgium
[4] Ghent Univ Hosp, Dept Radiol, Ghent, Belgium
[5] Ghent Univ Hosp, Dept Pathol, Ghent, Belgium
[6] Ghent Univ Hosp, Dept Gastroenterol, Ghent, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e14057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14057
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer
    de Geus-Oei, L. F.
    van Laarhoven, H. W. M.
    Visser, E. P.
    Hermsen, R.
    van Hoorn, B. A.
    Kamm, Y. J. L.
    Krabbe, P. F. M.
    Corstens, F. H. M.
    Punt, C. J. A.
    Oyen, W. J. G.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (02) : 348 - 352
  • [2] PET AS A PREDICTOR OF METABOLIC RESPONSE TO ANTIANGIOGENIC THERAPY IN METASTATIC COLORECTAL CANCER (MCRC)
    Van Damme, Nancy
    De Bruyne, Sylvie
    Ferdinande, Liesbeth
    Ceelen, Wim
    Mertens, Jeroen
    Van de Wiele, Christophe
    Laurent, Stephanie
    Smeets, Peter
    Geboes, Karen
    Peeters, Marc
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v92 - v92
  • [3] Is positron emission tomography (PET) with FDG an early predictor of the RECIST morphological response to chemotherapy in metastatic colorectal cancer patients (mCRC)?
    Hendlisz, A.
    Emonts, P.
    Covas, A.
    Ameye, L.
    Paesmans, M.
    del Rosario, R. Castany Prado Maria
    Machiels, G.
    Van den Eynde, M.
    Vanderlinden, B.
    Flamen, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Serial FDG-PET/CT for early and late metabolic response assessment during Sorafenib containing treatment of metastatic colorectal cancer (mCRC) patients
    Woff, E.
    Garcia, C.
    Hendlisz, A.
    Deleporte, A.
    Guiot, T.
    Flamen, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S523 - S524
  • [5] FDG-PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?
    Arslan, C.
    Kilickap, S.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (06) : 1149 - 1150
  • [6] Therapy monitoring with FDG-PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss, A
    Rudi, J
    Strauss, LG
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 113P - 113P
  • [7] Chemotherapy Response Evaluation in Metastatic Colorectal Cancer with FDG PET/CT and CT Scans
    Monteil, J.
    Mahmoudi, N.
    Leobon, S.
    Roudaut, P. Y.
    El Badaoui, A.
    Verbeke, S.
    Venat-Bouvet, L.
    Martin, J.
    Le Brun-Ly, V.
    Lavau-Denes, S.
    Maubon, A.
    Bouillet, P.
    Pouquet, M.
    Vandroux, J. C.
    Tubiana-Mathieu, N.
    [J]. ANTICANCER RESEARCH, 2009, 29 (07) : 2563 - 2568
  • [8] CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
    Skougaard, Kristin
    Johannesen, Helle Hjorth
    Nielsen, Dorte
    Schou, Jakob Vasehus
    Jensen, Benny Vittrup
    Hogdall, Estrid V. S.
    Hendel, Helle Westergren
    [J]. CANCER MEDICINE, 2014, 3 (05): : 1294 - 1301
  • [9] Reply to FDG-PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?
    Bystrom, P.
    Glimelius, B.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (06) : 1150 - 1150
  • [10] ASSESSING TUMOR RESPONSE TO CHEMOTHERAPY IN PEDIATRIC METASTATIC COLORECTAL CANCER: THE USE OF CEA AND FDG-PET/CT
    Drezner, Nicole
    Doros, Leslie
    Rossi, Chris
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 : S82 - S82
12345